1H-Imidazole-5-methanol, 2-butyl-4-chloro-1-[[2'-(2H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-, potassium salt (1:1)(CAS: 124750-99-8)
![1H-Imidazole-5-methanol, 2-butyl-4-chloro-1-[[2'-(2H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-, potassium salt (1:1) 1H-Imidazole-5-methanol, 2-butyl-4-chloro-1-[[2'-(2H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-, potassium salt (1:1)](https://cnstatic.chemtradehub.com/structs/124/124750-99-8-91eb.webp)
CAS号
相关产品
其他供应商提供的 1H-Imidazole-5-methanol, 2-butyl-4-chloro-1-[[2'-(2H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-, potassium salt (1:1)
基本信息
分子式
C22H22ClKN6O
分子量
461 g/mol
Physical Properties
熔点
268-271°C
沸点
682°C at 760 mmHg
密度
0.986g/mLat 25°C(lit.)
闪点
366.3 °C
化学标识符
SMILES
CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NN=N[N-]4)CO)Cl.[K+]
InChIKey
OXCMYAYHXIHQOA-UHFFFAOYSA-N
数据库引用
MDL号
MFCD02092704
常见问题
氯沙坦钾是一种血管紧张素II受体拮抗剂,化学名称为1H-Imidazole-5-methanol, 2-butyl-4-chloro-1-[[2'-(2H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-, potassium salt (1:1)。其CAS号为124750-99-8,主要用于治疗高血压和心力衰竭等心血管疾病。该化合物通过阻断血管紧张素II与其受体的结合,从而降低血压和改善心脏功能。
氯沙坦钾主要用于治疗高血压和心力衰竭。它作为血管紧张素II受体拮抗剂,能够有效降低血压并减轻心脏负担,适用于伴有糖尿病或肾功能不全的高血压患者。此外,它还可用于预防和治疗心血管事件,如心肌梗死和中风。
氯沙坦钾在推荐剂量下通常被认为是安全的,但需注意其可能的副作用,如头晕、腹泻、背痛等。患者在使用前应咨询医生,尤其是那些有肾功能不全、高钾血症或过敏史的人。使用时应避免与其他降压药物同时使用,以防止血压过低。
氯沙坦钾应储存在阴凉、干燥、避光的环境中,温度控制在15-30°C之间,相对湿度不超过60%。建议使用密封容器保存,以防止受潮和污染。避免与强酸、强碱或其他不相容物质接触。储存时应远离儿童和热源。
安全须知
使用前请验证产品规格和安全数据。联系供应商获取详细安全信息。
请始终遵循正确的操作程序

![(3S)-2-{N-[(2S)-1-Ethoxy-1-oxo-4-phenyl-2-butanyl]-L-alanyl}-1,2,3,4-tetrahydro-3-isoquinolinecarboxylic acid hydrochloride (1:1)](https://cnstatic.chemtradehub.com/structs/825/82586-55-8-c287.webp)

![(1S,2S,3R,4S,7R,9S,10S,12R,15S)-4,12-bis(acetyloxy)-1,9-dihydroxy-15-{[(2R,3S)-2-hydroxy-3-phenyl-3-(phenylformamido)propanoyl]oxy}-10,14,17,17-tetramethyl-11-oxo-6-oxatetracyclo[11.3.1.0^{3,10}.0^{4,7}]heptadec-13-en-2-yl benzoate](https://cnstatic.chemtradehub.com/structs/330/33069-62-4-4aa0.webp)
![N-Pentanoyl-N-{[2'-(1H-tetrazol-5-yl)-4-biphenylyl]methyl}-L-valine](https://cnstatic.chemtradehub.com/structs/137/137862-53-4-85fe.webp)

![{(1S,4R)-4-[2-Amino-6-(cyclopropylamino)-9H-purin-9-yl]-2-cyclopenten-1-yl}methanol](https://cnstatic.chemtradehub.com/structs/136/136470-78-5-94f8.webp)

![N-(2-Butyl-3-{4-[3-(dibutylamino)propoxy]benzoyl}-1-benzofuran-5-yl)methanesulfonamide hydrochloride (1:1)](https://cnstatic.chemtradehub.com/structs/141/141625-93-6-b862.webp)
![(1R,2S,6R,7S)-4-Azatricyclo[5.2.1.0~2,6~]decane-3,5-dione](https://cnstatic.chemtradehub.com/structs/148/14805-29-9-0fad.webp)
![1H-Imidazole-5-methanol, 2-butyl-4-chloro-1-[[2'-(2H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-, potassium salt (1:1) — 天门恒昌化工有限公司](https://cnstatic.chemtradehub.com/suppliers/67cecc092b2de6e8e95a5bbe/67cecc092b2de6e8e95a5bbe-logo.webp)
![1H-Imidazole-5-methanol, 2-butyl-4-chloro-1-[[2'-(2H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-, potassium salt (1:1) — 赫澎(上海)生物科技有限公司](https://cnstatic.chemtradehub.com/suppliers/67ceccf22b2de6e8e95a5e0f/67ceccf22b2de6e8e95a5e0f-logo.webp)
![1H-Imidazole-5-methanol, 2-butyl-4-chloro-1-[[2'-(2H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-, potassium salt (1:1) — 浙江华海药业股份有限公司](https://cnstatic.chemtradehub.com/suppliers/67cec4cd2b2de6e8e95a4f40/67cec4cd2b2de6e8e95a4f40-logo.webp)
![1H-Imidazole-5-methanol, 2-butyl-4-chloro-1-[[2'-(2H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-, potassium salt (1:1) — 湖北广奥生物科技有限公司](https://cnstatic.chemtradehub.com/suppliers/67cecc352b2de6e8e95a5c3b/67cecc352b2de6e8e95a5c3b-logo.webp)